Alcoa to Invest $284m Build an Anode Plant in Norway

Alcoa today announced it will invest approximately $284 million of the $314 million to build a new anode plant that will be built in Mosjoen, Norway.

The facility, which will be built together with Elkem ASA, will produce anodes for Alcoa's Fjardaal smelter in Iceland and the Mosjoen smelter in Norway, which is 50% held by Alcoa and Elkem. In addition, Alcoa owns 46% of the outstanding shares of Elkem. Construction of the anode plant is expected to be completed by 2007, in time to supply anodes for Alcoa Fjardaal, which will come on-line in 2007. Construction is contingent on government approvals. Upon completion, it is anticipated that the new anode facility will generate approximately 80 new permanent jobs in Mosjoen, not including local construction jobs.

Anodes used in Mosjoen were previously purchased, but an analysis of the process showed significant financial benefits to self-production. Anodes are the electrodes toward which current flows during the smelting process of making aluminum. The new facility is being built to meet the demand for anodes. Alcoa's inert anode project, while promising, is still in the research and development stage and won't be ready for full commercial deployment in time for the Iceland smelter's start of production.

In addition to expanding its presence in Mosjoen, Alcoa also has growing operations in Lista where it produces advanced automotive castings found on numerous automobiles and light trucks worldwide, and a 50 percent stake in the 90,000 metric ton per year Lista aluminum smelter (Elkem holds the remaining 50 percent).

For more information on aluminium, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.